Clinical Trial Update: A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Mircera (C.E.R.A.) for anemia in patients with pre-dialysis chronic kidney disease. The study has completed and its results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Mircera (C.E.R.A.) (darbepoetin alfa)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: COMPLETED | Results posted: 2015-10-26